Evidence map›Paper›PMID 25668511›Full record

ArticlePloS one2015

Weight loss by Ppc-1, a novel small molecule mitochondrial uncoupler derived from slime mold.

Toshiyuki Suzuki, Haruhisa Kikuchi, Masato Ogura, Miwako K Homma, Yoshiteru Oshima, Yoshimi Homma

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Non-'classical' MEKs: A review of MEK3-7 inhibitors.Bioorganic & medicinal chemistry letters · 2020
    Review
  6. 6-Amino[1,2,5]oxadiazolo[3,4-Journal of medicinal chemistry · 2020
    Article
  7. [1,2,5]Oxadiazolo[3,4-Journal of medicinal chemistry · 2020
    Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Toshiyuki SuzukiFukushima Medical University School of Medicine, Fukushima, 960-1295, Japan.
Haruhisa KikuchiGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, 980-8678, Japan.
Masato OguraFukushima Medical University School of Medicine, Fukushima, 960-1295, Japan.
Miwako K HommaFukushima Medical University School of Medicine, Fukushima, 960-1295, Japan.
Yoshiteru OshimaGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, 980-8678, Japan.
Yoshimi HommaFukushima Medical University School of Medicine, Fukushima, 960-1295, Japan.
Fukushima Medical University · JPTohoku Medical and Pharmaceutical University · JPTohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondria play a key role in diverse processes including ATP synthesis and apoptosis. Mitochondrial function can be studied using inhibitors of respiration, and new agents are valuable for discovering novel mechanisms involved in mitochondrial regulation. Here, we screened small molecules derived from slime molds and other microorganisms for their effects on mitochondrial oxygen consumption. We identified Ppc-1 as a novel molecule which stimulates oxygen consumption without adverse effects on ATP production. The kinetic behavior of Ppc-1 suggests its function as a mitochondrial uncoupler. Serial administration of Ppc-1 into mice suppressed weight gain with no abnormal effects on liver or kidney tissues, and no evidence of tumor formation. Serum fatty acid levels were significantly elevated in mice treated with Ppc-1, while body fat content remained low. After a single administration, Ppc-1 distributes into various tissues of individual animals at low levels. Ppc-1 stimulates adipocytes in culture to release fatty acids, which might explain the elevated serum fatty acids in Ppc-1-treated mice. The results suggest that Ppc-1 is a unique mitochondrial regulator which will be a valuable tool for mitochondrial research as well as the development of new drugs to treat obesity.

Indexed as

Adenosine TriphosphateAdipose TissueAnimalsDictyosteliidaFatty AcidsFemaleKidneyLiverMiceMice, Inbred ICRMitochondriaOxygen ConsumptionSmall Molecule LibrariesWeight LossAdenosine TriphosphateFatty AcidsSmall Molecule Libraries

Identifiers

PMID25668511
PMCPMC4323345
OpenAlexW1997026546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.